| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 241 | LACTOCOCCUS LACTIS STRAINS FOR THE PRODUCTION OF BIOACTIVE PEPTIDES HAVING ANTI-HYPERTENSIVE AND CHOLESTEROL-LOWERING EFFECTS | US14509925 | 2014-10-08 | US20150064271A1 | 2015-03-05 | Belinda Vallejo Galland; Aarón Fernando González Córdova; Jóse Carlos Rodríguez Figueroa |
| New Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation. | ||||||
| 242 | QUARK BASE MIX HAVING ENHANCED TASTE PROPERTIES III | US14459786 | 2014-08-14 | US20150050386A1 | 2015-02-19 | Marina Schomacker; Michael Hahn; Sven-Rainer Döring |
| A quark base mix is proposed having enhanced taste properties which is obtainable in that (a) raw milk is subjected to a temperature treatment and the cream is separated off, (b) the resultant skimmed milk is subjected to an ultrafiltration and in this case a first retentate R1 which contains a milk protein concentrate is produced, and a first permeate P1 is produced, (c) the first permeate P1 is subjected to a nanofiltration and/or reverse osmosis and in this case a second retentate R2 which contains alkali metal salts is produced, and a second permeate P2 is produced, (d) optionally the second retentate R2 is subjected to an alkaline demineralization and in this case a third retentate R3 which contains phosphate salts is produced and a third permeate P3 is produced, (e) the third permeate P3 is combined with the retentate R1 in such a manner that a non-acidified quark base mix is formed, and (f) the resultant mixture is subjected to a temperature treatment until denaturation occurs, and finally (g) the denatured product is admixed with starter cultures and rennet and optionally (h) the quark base mix thus obtained after completion of fermentation is adjusted to a defined dry matter content and protein content, and in step (g), as starter culture (i) a first mixture of five microorganisms comprising (i-1) Streptococcus thermophilus, (i-2) Leuconostoc species, (i-3) Lactococcus lactis subsp. lactis biovar diacetylactis, (i-4) Lactococcus lactis subsp. lactis and (i-5) Lactococcus lactis subsp. cremoris, and (ii) a second mixture of three microorganisms comprising (ii-1) Streptococcus thermophilus, (ii-2) Lactococcus lactis subsp. lactis and (ii-3) Lactococcus lactis subsp. cremoris is used. | ||||||
| 243 | METHOD FOR MAKING CHEESE | US14366552 | 2012-12-21 | US20140348978A1 | 2014-11-27 | Kirsten Kastberg Moeller; Fergal Rattray; Erik Hoeier; Yiva Ardoe |
| The present invention relates to a method for producing cheese with good flavour, especially low-salt cheese by using a lactic acid bacteria (LAB) starter culture which is glutamate decarboxylation (GAD) negative. The method may additionally involve inoculating the milk substrate with a GAD-negative Lb. helveticus strain having a high lytic and peptidolytic activity, which further releases glutamate into the milk Additional application of camel chymosin reduces bitterness. | ||||||
| 244 | AGENT FOR INDUCING INTERFERON PRODUCTION CONTAINING LACTIC ACID BACTERIA | US14263306 | 2014-04-28 | US20140234379A1 | 2014-08-21 | Daisuke Fujiwara; Kenta JONAI; Tetsu SUGIMURA |
| This invention provides an IFN inducer comprising, as an active ingredient, lactic acid bacteria and capable of inducing IFN production, an immunopotentiating agent or prophylactic agent against virus infection comprising such inducer, and a food or drink product comprising such IFN inducer and having IFN-inducing activity, immunopotentiating activity, or prophylactic activity against virus infection. The agent for inducing IFN production comprises, as active ingredients, lactic acid bacteria that can activate plasmacytoid dendritic cells (pDCs) and promote IFN production, such as Lactococcus garvieae NBRC100934, Lactococcus lactis subsp. cremoris JCM16167, Lactococcus lactis subsp. cremoris NBRC100676, Lactococcus lactis subsp. hordniae JCM1180, Lactococcus lactis subsp. hordniae JCM11040, Lactococcus lactis subsp. lactis NBRC12007, Lactococcus lactis subsp. lactis NRIC1150, Lactococcus lactis subsp. lactis JCM5805, Lactococcus lactis subsp. lactis JCM20101, Leuconostoc lactis NBRC12455, Leuconostoc lactis NRIC1540, Pediococcus damnosus JCM5886, or Streptococcus thermophilus TA-45. | ||||||
| 245 | Complete liquid nutrition for children at the age of 1-10 years comprising probiotics | US13319961 | 2010-05-11 | US08603492B2 | 2013-12-10 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 246 | FLAVOUR MODULATION BY BIO-PROCESSING USING FLAVOUR FORMING BACTERIA STRAINS | US13995432 | 2011-12-20 | US20130273201A1 | 2013-10-17 | Marcel Braun |
| A fermentation of a milk source with Lactococcus lactis subsp. lactis biovar diacetylactis (CNCM No. I-1962) to form a fermented milk product. The fermented milk product has a flavour and aroma. The fermented milk product can be in the form of a powder or a concentrate. The fermented milk product has applications in the food industry. | ||||||
| 247 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS | US13901176 | 2013-05-23 | US20130260440A1 | 2013-10-03 | Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 248 | GROWING UP MILKS CONTAINING PROBIOTIC MICRO-ORGANISMS | US13319477 | 2010-05-11 | US20120269789A1 | 2012-10-25 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 249 | ORAL NUTRITIONAL SUPPLEMENT FOR CHILDREN COMPRISING PROBIOTICS | US13319943 | 2010-05-11 | US20120189598A1 | 2012-07-26 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | ||||||
| 250 | NUTRITIONALLY BALANCED STANDARD TUBE FEEDING FORMULA CONTAINING PROBIOTICS | US13319947 | 2010-05-11 | US20120141444A1 | 2012-06-07 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 251 | INFANT FEEDING FORMULAS COMPRISING PROBIOTIC MICRO-ORGANISMS | US13319627 | 2010-05-11 | US20120128726A1 | 2012-05-24 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 252 | BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS | US13319965 | 2010-05-11 | US20120121685A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 253 | SPECIALIZED NUTRITIONAL FORMULA FOR ADULT PATIENTS WITH GASTROINTESTINAL INTOLERANCE CONTAINING PROBIOTICS | US13319949 | 2010-05-11 | US20120121563A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for adults. In particular, the present invention relates to the nutritional compositions intended for adults with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to adults with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 254 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN | US13319638 | 2010-05-11 | US20120064051A1 | 2012-03-15 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 255 | LACTIC ACID BACTERIA AND THEIR CELLULAR COMPONENTS INDUCING IMMUNOREGULATORY FUNCTION, AND METHOD OF OBTAINING THE SAME | US12615861 | 2009-11-10 | US20110269165A1 | 2011-11-03 | NORIKO TSUJI; HIROMI KIMOTO |
| To provide a microorganism and an ingredient thereof that contribute to prevention and treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer), a method of effectively selecting the microorganism, and a method of efficiently inducing immunoregulatory cells that play an important role on maintaining immunological homeostasis using the microorganism or the ingredient thereof. The present invention provides a Lactococcus and an ingredient thereof which induce production of IL-b from mammalian dendritic or spleen cells, a method of obtaining the microorganism or the ingredient thereof by co-culturing a microorganism such as Lactococcus strains with mammalian dendritic or spleen cells to select a microbial cell having a high IL-b production ability, a method of selecting the microorganism or the ingredient thereof by co-culturing an intestinal epithelial cell with a microorganism such as the lactic acid bacteria and selecting the cells on the basis of a caspase-1 activity and the ability of inducing the production of IL-18, and a food product or material and an animal feeding stuff or medical and pharmaceutical products which contain the lactic acid bacteria as an effective ingredient. | ||||||
| 256 | COMPOSITION FOR MAKING A DAIRY PRODUCT | US13124914 | 2009-11-02 | US20110256266A1 | 2011-10-20 | Brian J. Orme; Randall Kirk Thunell; Paul Gerard Bruinenberg |
| The present invention relates to improved bulk starter cultures and their use in the manufacture of fermented products. The present invention also relates to methods for making the improved bulk starter cultures. | ||||||
| 257 | Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients | US12091257 | 2006-09-22 | US20090028840A1 | 2009-01-29 | Sin Hyeog Im; Jae Seon So; Hwa Joong Yi |
| The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis. | ||||||
| 258 | Microbial oxygen absorber | US11602328 | 2006-11-21 | US20070212461A1 | 2007-09-13 | Soren Lillevang; Grith Mortensen; Mette Kristensen; Henrik Pedersen; Torben Friis; Niels Sorensen |
| Improved packaging and method for prolonging the shelf life and quality of packaged foods. | ||||||
| 259 | Process to improve milk coagulation by means of strains of lactic bacteria, new strains and their use in said process | US10538151 | 2003-12-03 | US20060008554A1 | 2006-01-12 | Giovanni Mogna |
| The present invention relates to a process to improve milk coagulation principally for dairy purposes, comprising pre-treatment of the milk with appropriate strains of 5 lactic bacteria, new strains of lactic bacteria and their use in the process. | ||||||
| 260 | Peptides with anti-hypertensive properties | US10956084 | 2004-10-04 | US20050142166A1 | 2005-06-30 | Benedicte Flambard |
| A process for preparing peptides with anti-hypertensive properties and a process for preparing a functional food product comprising peptides with anti-hypertensive properties. | ||||||
QQ群二维码
意见反馈
意见反馈